Home Newsfeeds Procaps Gr Q3 Sales $110.00M

Procaps Gr Q3 Sales $110.00M

Procaps Gr (NASDAQ:PROC) reported quarterly sales of $110.00 million which missed the analyst consensus estimate of $123.90 million by 11.22 percent.

byMichael Horton

November 14, 2022

1 minute read

Procaps Gr (NASDAQ:PROC) reported quarterly sales of $110.00 million which missed the analyst consensus estimate of $123.90 million by 11.22 percent.

B of A Securities Upgrades Kite Realty Gr Trust to Buy, Raises Price Target to $25

By Benzinga Newsdesk

November 9, 7:27 AM

B of A Securities analyst Craig Schmidt upgrades Kite Realty Gr Trust (NYSE:KRG) from Neutral to Buy and raises the price target from $22 to $25.

KRG

Why Are NanoViricides Shares Gaining Today

By Vandana Singh

July 11, 12:51 PM

NanoViricides Inc (NYSE: NNVC) shares are trading higher after the company reported preclinical data from an antiviral clinical drug candidate for

GSK

Reported Late Thursday, Myriad Genetics Patient Outcomes Study Shows RiskScore Leads To More Accurate Breast Cancer Risk Prediction Than Standard-Of-Care Risk Model

By Benzinga Newsdesk

December 9, 2:40 AM

Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today presented results from a longitudinal study validating RiskScore as a well-calibrated and more accurate predictor

MYGN

ReNew Announces The Signing Of 5 Power Purchase Agreements Totaling ~2.2 GW Of RE Capacity, Expanding Its Fully Contracted Renewable Energy Portfolio

By Benzinga Newsdesk

May 9, 10:33 AM

Our first FDRE PPA signed with SJVN for RE development of ~1 GW15.6 GW RE portfolio is one of the largest globally ReNew, India's leading renewable energy company (NASDAQ:RNW), has announced the signing of five

RNW

Procaps Gr Q3 Sales $110.00M

Related Posts

B of A Securities Upgrades Kite Realty Gr Trust to Buy, Raises Price Target to $25

Why Are NanoViricides Shares Gaining Today

Reported Late Thursday, Myriad Genetics Patient Outcomes Study Shows RiskScore Leads To More Accurate Breast Cancer Risk Prediction Than Standard-Of-Care Risk Model

ReNew Announces The Signing Of 5 Power Purchase Agreements Totaling ~2.2 GW Of RE Capacity, Expanding Its Fully Contracted Renewable Energy Portfolio